Glycoprotein IIb/IIIa inhibitors are frequently used during percutaneous coronary intervention (angioplasty with or without intracoronary stent placement).
P-glycoprotein | glycoprotein | P-selectin glycoprotein ligand-1 | Glycoprotein | Variable surface glycoprotein | Glycoprotein IIb/IIIa |
Eptifibatide (Integrilin, Millennium Pharmaceuticals, also co-promoted by Schering-Plough/Essex), is an antiplatelet drug of the glycoprotein IIb/IIIa inhibitor class.